J&J to buy eye disease biotech Ollin Biosciences for up to $3.3B
Johnson & Johnson said Monday it will snap up Ollin Biosciences in a deal worth up to $3.3 billion, just a …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Source link







